View in EDS PDF Full Text

DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials.

Saved in:
Bibliographic Details
Title: DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials.
Authors: Morgan, C.1, Jin, X.2, Yu, X.1, De Rosa, S.1, Kublin, J.1, Metch, B.1, Keefer, M.2, Niaid, H.1
Source: Retrovirology. 2012 Supplement, Vol. 9 Issue Suppl 2, p1-1. 1p.
Database: Academic Search Ultimate
Description
ISSN:17424690
DOI:10.1186/1742-4690-9-S2-P133